Medical Marijuana, Inc.’s Investment AXIM® Biotech Files IP Application on Proprietary Method to Extract High-Purity THC

by adminTorusBrand | Nov 29, 2016 | Axim Biotechnologies, Press Releases

Company’s major investment company announces filing of protection for proprietary method of THC extraction that will achieve highest THC purity level on the market. SAN DIEGO – Nov. 29, 2016 – Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded...

Axim® Biotechnologies, Inc. Donates Flagship CanChew Gum to U.S. Pain Foundation to Help Chronic Pain Sufferers

by adminTorusBrand | Nov 22, 2016 | Axim Biotechnologies, Press Releases

NEW YORK, Nov. 22, 2016 (GLOBE NEWSWIRE) — AXIM®Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that it has donated 3,200 pieces of its hemp-derived CBD functional chewing gum CanChew® to...

Medical Marijuana, Inc. CEO Dr. Stuart Titus Discusses Booming Cannabis Industry on U-T Community Spotlight

by adminTorusBrand | Nov 21, 2016 | Axim Biotechnologies, Company News, Media Coverage, Scientific Research

Medical Marijuana, Inc. president and CEO featured on San Diego Union-Tribune radio show to talk about new developments in the marijuana industry. Dr. Stuart Titus, CEO of Medical Marijuana, Inc., took time away from the 5th Annual Marijuana Business Conference and...

AXIM® Biotechnologies Patent on Delayed Release Cannabidiol Gum Extended to Include All Cannabinoids

by adminTorusBrand | Nov 17, 2016 | Axim Biotechnologies, Company News

Medical Marijuana, Inc. investment company AXIM® Biotechnologies announced this week that the United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for U.S. Application Serial Number 9,433,601, a patent owned by the company that claims the use...

U.S. Patent Allowance Granted to Medical Marijuana, Inc.’s Investment AXIM(R) Biotech for Use of All Cannabinoids in Its Controlled Release Chewing Gum

by adminTorusBrand | Nov 16, 2016 | Axim Biotechnologies, Press Releases

SAN DIEGO, CA–(Marketwired – November 16, 2016) – Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that its major investment AXIM® Biotechnologies, Inc. (AXIM® Biotech) (AXIM), a world leader in hemp cannabinoid research and development,...

Why Big Pharma is Scared of Cannabinoids – and How Medical Marijuana, Inc. is Bridging the Gap

by adminTorusBrand | Nov 11, 2016 | Axim Biotechnologies, Company News, Industry Updates, Kannalife Sciences

[vc_row][vc_column][vc_column_text]As cannabis continues to expand into a multi-billion dollar international market, other sectors of the economy are beginning to feel the effects of this new industry’s growth – none more so than pharmaceuticals. This raises an...